This proprietary platform offers the opportunity to use a variety of ligands releasable linkers and drugs to create a pipeline of SMDC candidates for research and companion imaging agents for clinical development.
This proprietary platform offers the opportunity to use a variety of ligands, releasable linkers, and drugs to create a pipeline of novel SMDC candidates and companion imaging agents for clinical development.